Status:
UNKNOWN
Pericapsular Nerve Group (PENG) Block Combined With Periarticular Multimodal Drug Injection (PMDI) Versus Isolated PMDI for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial
Lead Sponsor:
Yonsei University
Conditions:
Total Hip Arthroplasty, Postoperative Pain
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Adequate pain control after total hip arthroplasty is crucial for early ambulation and patient satisfaction. However, there is no consensus about optimal pain control after post operation. In general,...
Eligibility Criteria
Inclusion
- 1\. Patients aged 19 years old or older, with American Society of Anesthesiologists Physical Status 1-3, and scheduled for elective unilateral total hip arthroplasty
Exclusion
- Allergy or intolerance to any of the drugs used in the study
- Hepatic or renal insufficiency
- Opioid dependency
- Coagulopathy
- Pre-existing neurologic or anatomic deficits in the lower extremities
- Severe psychiatric illness
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 13 2023
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT05320913
Start Date
April 4 2022
End Date
December 13 2023
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea